Follow us on Twitter
twitter icon@FreshPatents


Bowel patents

      

This page is updated frequently with new Bowel-related patent applications.




 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaecutical use patent thumbnailTetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaecutical use
The present invention relates to nordihydroguaiaretic acid derivative compounds, namely, butane bridge modified nordihydroguaiaretic acid (ndga) compounds and butane bridge modified tetra-o-substituted ndga compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them and kits including them for the treatment of diseases and disorders, in particular, diseases resulting from or associated with a virus infection, such as hiv infection, hpv infection, or hsv infection, an inflammatory disease, such as various types of arthritis and inflammatory bowel diseases, metabolic diseases, such as diabetes and hypertension, or a proliferative disease, such as diverse types of cancers.. .
Erimos Pharmaceuticals Llc


 Bacterial phospholipase inhibitors as modulator of colonic bacterial flora patent thumbnailBacterial phospholipase inhibitors as modulator of colonic bacterial flora
The present invention relates to the field of gastroenterology and, more particular, to the field of intestinal diseases. More specifically, it concerns uses and methods for the treatment of inflammatory bacterial diseases of the intestine.
Universitaetsklinikum Heidelberg


 Selective opioid compounds patent thumbnailSelective opioid compounds
Which relates to mophinan compounds useful as μ, δ and/or κ receptor opioid compounds and pharmaceuticals containing same that may be useful for mediating analgesia, combating drug addiction, alcohol addiction, drug overdose, mental illness, bladder dysfunctions, neurogenic bladder, interstitial cystitis, urinary incontinence, premature ejaculation, inflammatory pain, peripherally mediated and neuropathic pain, cough, lung edema, diarrhea, cardiac disorders, cardioprotection, depression, and cognitive, respiratory, diarrhea, irritable bowel syndrome and gastro-intestinal disorders, immunomodulation, and anti-tumor agents.. .

 Treatment of irritable bowel syndrome patent thumbnailTreatment of irritable bowel syndrome
A method of treating irritable bowel syndrome in a patient in need thereof by administering to said patient a pharmaceutically effective amount of tapentadol.. .
Gruenenthal Gmbh


 Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease patent thumbnailDiagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
The present invention describes methods, assays, and systems of diagnosing, selecting and treating irritable bowel syndrome (ibs) based on a subject's level of anti-vinculin and anti-cdtb antibodies. Ibs can be distinguished from inflammatory bowel (ibd) disease using the methods, assays, and systems described herein..
Cedars-sinai Medical Center


 Anti-human il-21 antibodies patent thumbnailAnti-human il-21 antibodies
Monoclonal antibodies are identified that bind the il-21 protein. These antibodies are used to identify regions of the il-21 protein to where binding neutralizes il-21 activity.
Zymogenetics, Inc.


 Topical composition for use in the treatment of inflammatory bowel disease patent thumbnailTopical composition for use in the treatment of inflammatory bowel disease
The present invention relates to a topical composition containing a probiotic and hyaluronic acid or a pharmaceutically acceptable salt thereof, for use in the treatment and/or prevention of inflammatory bowel disease.. .
Sofar Spa


 Novel lactobacillus plantarum and composition containing same patent thumbnailNovel lactobacillus plantarum and composition containing same
The present invention provides lactobacillus plantarum cjlp55 kctc 11401bp, a composition for treating bowel disease containing the lactobacillus, and a composition for immunological enhancement containing the lactobacillus.. .
Cj Cheiljedang Corp.


 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption patent thumbnailMethods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
The invention relates generally to digestive disorders, and in particular to methods for treating irritable bowel syndrome by increasing carbohydrate absorption by administering a composition containing a bacillus coagulans bacterium.. .
Ganeden Biotech, Inc.


 Novel compounds useful for the treatment of degenerative and inflammatory diseases patent thumbnailNovel compounds useful for the treatment of degenerative and inflammatory diseases
The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, diseases involving cartilage degradation, bone and/or joint degradation, for example osteoarthritis; and/or conditions involving inflammation or immune responses, such as crohn's disease, rheumatoid arthritis, psoriasis, allergic airways disease (e.g. Asthma, rhinitis), juvenile idiopathic arthritis, colitis, inflammatory bowel diseases, endotoxin-driven disease states (e.g.

Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

The invention provides novel guanylate cyclase-c agonist peptides and their use in the treatment of human diseases including gastrointestinal disorders, inflammation or cancer (e.g., a gastrointestinal cancer). The peptides can be administered either alone or in combination with an inhibitor of cgmp-dependent phosphodiesterase.
Synergy Pharmaceuticals, Inc.

5-ht2b antagonists

And related methods for treating a person having a disorder characterized by undesirable 5-ht2b receptor signaling, such as migraine, irritable bowel syndrome (ibs), pulmonary arterial hypertension (pah), fibrosis, hepatocellular cancer, a small intestinal neuroendocrine tumor, cardiovascular disorders, and gastrointestinal (gi) tract disorders.. .

Treatment of short bowel syndrome patients with colon-in-continuity

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a glp-2 receptor agonist, such as teduglutide.. .
Nps Pharmaceuticals, Inc.

Treatment of short bowel syndrome patients with colon-in-continuity

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a glp-2 receptor agonist, such as teduglutide.. .
Nps Pharmaceuticals, Inc.

Treatment of short bowel syndrome patients with colon-in-continuity

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a glp-2 receptor agonist, such as teduglutide.. .
Nps Pharmaceuticals, Inc.

Treatment of short bowel syndrome patients with colon-in-continuity

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a glp-2 receptor agonist, such as teduglutide.. .
Nps Pharmaceuticals, Inc.

Treatment of short bowel syndrome patients with colon-in-continuity

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a glp-2 receptor agonist, such as teduglutide.. .
Nps Pharmaceuticals, Inc.

Treatment of short bowel syndrome patients with colon-in-continuity

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a glp-2 receptor agonist, such as teduglutide.. .
Nps Pharmaceuticals, Inc.

Treatment of short bowel syndrome patients with colon-in-continuity

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a glp-2 receptor agonist, such as teduglutide.. .
Nps Pharmaceuticals, Inc.



Bowel topics:
  • Bowel Disease
  • Inflammatory Bowel Disease
  • Irritable Bowel Syndrome
  • Inflammation
  • Mercaptopurine
  • Probiotics
  • Abdominal Pain
  • Discomfort
  • Bowel Movement
  • Gastrointestinal
  • Ulcerative Colitis
  • Rheumatoid Arthritis
  • Jejunal Tube
  • Spring Mechanism
  • Small Bowel


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Bowel for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bowel with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.7148

    file did exist - 2603

    0 - 1 - 51